Pharma DECODED
Latest edition: 24 May 2024
Share newsletter
Get the full version straight to your inbox.
Exclusive access to our best-in-class data & intelligence
Subscribe now
Spotlight
ASCO 2024: Verastem's combo therapy for pancreatic cancer hits early trial success
Shares in the pharma company rose 40% in pre-market trading.
Latest news
EC approves Celltrion's Omlyclo for allergic conditions
The approval is based on robust clinical evidence, including findings from a global Phase III clinical trial.
Zydus Lifesciences concludes subject enrolment in Phase II ALS trial
A total of 24 ALS patients were enrolled across seven study sites in India.
Terran Biosciences prepares for trials of schizophrenia drug
TerXT will be investigated in two Phase I trials before Terran will apply for approval after KarXT’s five-year exclusivity period.
Tango terminates USP1 inhibitor programme
The company licensed the ubiquitin-specific protease 1 (USP1) inhibiting cancer therapy from Medivir in 2020.
ASCO 2024: Merus touts positive Phase II data for head and neck cancer antibody
Shares in Merus rose by 15% in premarket trading, following the announcement of positive Phase II data to be presented at ASCO.
FDA advisory committee reviews Novo Nordisk insulin icodec for T1D
In the ONWARDS 6 trial, insulin icodec demonstrated a significantly higher rate of hypoglycaemic episodes.
Pfizer starts $1.5bn cost-cutting initiative amidst declining Covid-19 revenues
The cost saving programme is expected to save the company approximately $1.5bn by 2027.
In our previous edition
Pharma Decoded
Biogen enters deal to acquire HI-Bio for $1.8bn
23 May 2024
Pharma Decoded
Genmab acquires biotechnology company ProfoundBio in $1.8bn deal
22 May 2024
Pharma Decoded
AstraZeneca to establish $1.5bn ADC production site in Singapore
21 May 2024
Still looking?
Search companies, themes, reports, as well as actionable data & insights spanning 22 global industries
Explorer
Access more premium companies when you subscribe to Explorer